Teva Pharmaceutical Industries Limited (TEVA)

Teva Pharmaceutical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	3,226	2,801	2,165	2,177	1,975
Cash & Cash Equivalents	3,226	2,801	2,165	2,177	1,975
Cash Growth	15.17%	29.38%	-0.55%	10.23%	10.83%
Receivables	3,408	3,696	4,529	4,581	5,676
Inventory	4,021	3,833	3,818	4,403	4,422
Other Current Assets	1,830	1,721	2,061	1,844	1,391
Total Current Assets	12,485	12,051	12,573	13,005	13,464
Property, Plant & Equipment	6,147	6,158	6,477	6,855	6,950
Goodwill and Intangibles	22,564	23,903	27,506	29,547	36,078
Other Long-Term Assets	2,283	1,899	1,110	1,233	978
Total Long-Term Assets	30,994	31,960	35,093	37,635	44,006
Total Assets	43,479	44,011	47,666	50,640	57,470
Accounts Payable	2,602	1,887	1,686	1,756	1,718
Current Debt	1,672	2,109	1,426	3,188	2,345
Other Current Liabilities	7,973	7,473	7,915	8,220	9,611
Total Current Liabilities	12,247	11,469	11,027	13,164	13,674
Long-Term Debt	18,481	19,452	22,033	23,210	24,997
Other Long-Term Liabilities	4,625	4,492	3,362	3,205	3,736
Total Long-Term Liabilities	23,106	23,944	25,395	26,415	28,733
Total Liabilities	35,353	35,413	36,422	39,579	42,407
Total Debt	20,153	21,561	23,459	26,398	27,342
Debt Growth	-6.53%	-8.09%	-11.13%	-3.45%	-5.44%
Retained Earnings	-13,534	-12,975	-10,529	-10,946	-6,956
Comprehensive Income	-2,697	-2,838	-2,683	-2,399	-2,312
Shareholders' Equity	7,506	7,804	10,278	10,026	13,972
Net Cash / Debt	-16,927	-18,760	-21,294	-24,221	-25,367
Net Cash Per Share	-15.13	-16.90	-19.24	-22.12	-23.25
Working Capital	238	582	1,546	-159	-210
Book Value Per Share	6.71	7.03	9.33	9.16	12.81

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).